Skip to content

Author

A. Alaraibi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

The effects of tirzepatide and semaglutide on clinical and metabolic outcomes in patients with heart failure with preserved ejection fraction and obesity: a systematic review and meta-analysis.

BACKGROUND AND AIMS Heart failure with preserved ejection fraction (HFpEF) with obesity remains a therapeutic challenge with limited options. Glucagon-like peptide-1 (GLP-1) receptor agonists and dual incretin agonists may improve health status, functional capacity, and metabolic parameters. We evaluated the efficacy a...

A. Alaraibi, Fatema Naser Shakeeb, Tasneem A. Alqatta et al. · 0 citations
Review Open access Jul 2026

The effect of PCSK9 inhibitors on cardiovascular outcomes in diabetic patients: a narrative review

While the high cost and requirement for parenteral administration remain limitations, PCSK9 inhibitors represent a promising therapy for high-risk diabetic patients who fail to achieve lipid goals with conventional therapy and/or fail to adhere to the mainstay therapy due to adverse events.

Abu-Baker Khalid Sharafeldin, Noor Elhuda Taher Aljundi, Abdullah Hussain et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.